Rocket One (RKTO) Change in Account Payables (2018 - 2024)
Rocket One's (RKTO) quarterly Change in Account Payables came in at -$39305.0 in Q1 2024, up 16.77% year-over-year from -$33660.0 in Q2 2023, and up 96.83% quarter-over-quarter from -$1.2 million in Q4 2023.
Analysis
Rocket One (RKTO) Change in Account Payables (2018 - 2024) Analysis & Trends
Rocket One has disclosed Change in Account Payables across 7 years of filings, most recently posting -$39305.0 for Q1 2024.
- In Q1 2024, Change in Account Payables rose 16.77% year-over-year to -$39305.0; the TTM figure through Mar 2024 stood at -$692832.0 (down 216.18% YoY), while the FY2023 annual figure was -$700752.0, down 218.64% from the prior year.
- Change in Account Payables came in at -$39305.0 for Q1 2024 at Rocket One, up from -$1.2 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $453930.0 in Q1 2021 to a low of -$1.2 million in Q4 2023.
- Average Change in Account Payables over 5 years is $13760.4, with a median of $102278.0 recorded in 2020.
- Year-over-year, Change in Account Payables slumped 828.88% in 2021 and jumped 2571.93% in 2023.
- Over 5 years, Change in Account Payables stood at $102278.0 in 2020, then tumbled by 828.88% to -$745481.0 in 2021, then jumped by 146.32% to $345336.0 in 2022, then tumbled by 458.74% to -$1.2 million in 2023, then soared by 96.83% to -$39305.0 in 2024.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$39305.0 in Q1 2024, -$1.2 million in Q4 2023, and $207182.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | -70.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 18.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | -66.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -8.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 7.11 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -39,305.00 |
| Dec 31, 2023 | -1.24 Mn |
| Sep 30, 2023 | 207,182.00 |
| Jun 30, 2023 | 378,158.00 |
| Mar 31, 2023 | -47,225.00 |
| Dec 31, 2022 | 345,336.00 |
| Sep 30, 2022 | 284,058.00 |
| Jun 30, 2022 | 14,153.00 |
| Mar 31, 2022 | -52,915.00 |
| Dec 31, 2021 | -745,481.00 |
| Sep 30, 2021 | 412,793.00 |
| Jun 30, 2021 | 414,098.00 |
| Mar 31, 2021 | 453,930.00 |
| Dec 31, 2020 | 102,278.00 |
| Sep 30, 2020 | -149,722.00 |
| Jun 30, 2020 | -218,219.00 |
| Mar 31, 2020 | 113,675.00 |
| Dec 31, 2019 | 384,324.00 |
| Sep 30, 2019 | -181,953.00 |
| Jun 30, 2019 | 136,673.00 |